Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Vitamin D and Toxic Metals in Pregnancy - a Biological Perspective

    To discuss the potential biological mechanisms between vitamin D and toxic metals and summarize epidemiological studies examining this association in pregnant women.

    Mandy Fisher, Hope A. Weiler, Jordan R. Kuiper in Current Epidemiology Reports (2024)

  2. No Access

    Article

    Relationship Between Gestational Weight Gain and Health Service Utilization in Early Childhood: A Retrospective Cohort Study

    Gestational weight gain (GWG) outside recommended ranges can negatively impact both the woman and child. The long-term effects of below-recommended or above-recommended GWG on the child are unclear.

    Lisa M. Currie, Deshayne B. Fell, Steven Hawken in Maternal and Child Health Journal (2024)

  3. Article

    Open Access

    Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children

    Despite the critical importance of clinical trials to provide evidence about the effects of intervention for children and youth, a paucity of published high-quality pediatric clinical trials persists. Sub-opti...

    Ami Baba, Maureen Smith, Beth K. Potter, An-Wen Chan, David Moher in Trials (2024)

  4. Article

    Open Access

    Assessing the quality and value of metabolic chart data for capturing core outcomes for pediatric medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

    Generating rigorous evidence to inform care for rare diseases requires reliable, sustainable, and longitudinal measurement of priority outcomes. Having developed a core outcome set for pediatric medium-chain a...

    Ryan Iverson, Monica Taljaard, Michael T. Geraghty, Michael Pugliese in BMC Pediatrics (2024)

  5. Article

    Open Access

    Youth and family involvement in the development of a plain language trial results communication tool: CommuniKIDS

    Pediatric trials are possible through voluntary participation of children, youth (age ≤ 18 years), and their families. Despite important arguments for trialists to provide trial progress or results, and eviden...

    Ami Baba, Dawn P. Richards, Maureen Smith in Research Involvement and Engagement (2023)

  6. Article

    Open Access

    Ethical and practical considerations related to data sharing when collecting patient-reported outcomes in care-based child health research

    The collection and use of patient reported outcomes (PROs) in care-based child health research raises challenging ethical and logistical questions. This paper offers an analysis of two questions related to PRO...

    Shelley Vanderhout, Beth K. Potter, Maureen Smith in Quality of Life Research (2023)

  7. Article

    Open Access

    Maternal weight and paediatric health use: mediating role of adverse birth outcomes: a retrospective cohort study

    Maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) above or below recommendations have been associated with increased paediatric health service utilization as well as increased risk...

    Lisa M. Currie, Hilary K. Brown, Beth K. Potter in BMC Pregnancy and Childbirth (2023)

  8. Article

    Open Access

    Screening for depression among the general adult population and in women during pregnancy or the first-year postpartum: two systematic reviews to inform a guideline of the Canadian Task Force on Preventive Health Care

    Depression affects an individual’s physical health and mental well-being and, in pregnant and postpartum women, has specific adverse short- and long-term effects on maternal, child, and family health. The aim ...

    Andrew Beck, Candyce Hamel, Micere Thuku, Leila Esmaeilisaraji in Systematic Reviews (2022)

  9. Article

    Open Access

    Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey

    Children with inherited metabolic diseases often require complex and highly specialized care. Patient and family-centered care can improve health outcomes that are important to families. This study aimed to ex...

    Andrea J. Chow, Michael Pugliese in The Patient - Patient-Centered Outcomes Re… (2022)

  10. Article

    Open Access

    Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys

    Alison H. Howie, Kylie Tingley, Michal Inbar-Feigenberg, John J. Mitchell in Trials (2021)

  11. Article

    Open Access

    Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys

    Mucopolysaccharidoses (MPS) are a group of inherited metabolic diseases characterized by chronic, progressive multi-system manifestations with varying degrees of severity. Disease-modifying therapies exist to ...

    Alison H. Howie, Kylie Tingley, Michal Inbar-Feigenberg, John J. Mitchell in Trials (2021)

  12. Article

    Open Access

    Patient and family engagement in the development of core outcome sets for two rare chronic diseases in children

    Core outcome sets (COS) are lists of consensus-determined outcomes to be measured and reported in all clinical research studies within a disease area. While including patients and families in COS development t...

    Shelley M. Vanderhout, Maureen Smith, Nicole Pallone in Research Involvement and Engagement (2021)

  13. Article

    Open Access

    Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening

    Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an...

    Sara D. Khangura, Beth K. Potter, Christine Davies, Robin Ducharme in BMC Pediatrics (2021)

  14. Article

    Open Access

    Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research

    For many rare diseases, few treatments are supported by strong evidence. Patients, family members, health care providers, and policy-makers thus have to consider whether to accept, recommend, or fund treatment...

    Kylie Tingley, Doug Coyle, Ian D. Graham in Orphanet Journal of Rare Diseases (2021)

  15. Article

    Open Access

    Screening for depression in children and adolescents: a protocol for a systematic review update

    Major depressive disorder is common, debilitating, and affects feelings, thoughts, mood, and behaviors. Childhood and adolescence are critical periods for the development of depression and adolescence is marke...

    Andrew Beck, John C. LeBlanc, Kate Morissette, Candyce Hamel in Systematic Reviews (2021)

  16. No Access

    Article

    Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis

    Cannabinoid oils are being increasingly used to treat Dravet syndrome, yet the long-term costs and outcomes of this approach are unknown. Thus, we examined the cost effectiveness of cannabinoid oil as an adjun...

    Jesse Elliott, Bláthnaid McCoy, Tammy Clifford, Beth K. Potter in PharmacoEconomics (2020)

  17. Article

    Open Access

    Evaluation of the quality of clinical data collection for a pan-Canadian cohort of children affected by inherited metabolic diseases: lessons learned from the Canadian Inherited Metabolic Diseases Research Network

    The Canadian Inherited Metabolic Diseases Research Network (CIMDRN) is a pan-Canadian practice-based research network of 14 Hereditary Metabolic Disease Treatment Centres and over 50 investigators. CIMDRN aims...

    Kylie Tingley, Monica Lamoureux, Michael Pugliese in Orphanet Journal of Rare Diseases (2020)

  18. Article

    Open Access

    Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review

    Inherited metabolic diseases (IMDs) are a group of individually rare single-gene diseases. For many IMDs, there is a paucity of high-quality evidence that evaluates the effectiveness of clinical interventions....

    Michael Pugliese, Kylie Tingley, Andrea Chow in Orphanet Journal of Rare Diseases (2020)

  19. Article

    Open Access

    Utilization of key preventive measures for pregnancy complications and malaria among women in Jimma Zone, Ethiopia

    In Ethiopia, malaria infections and other complications during pregnancy contribute to the high burden of maternal morbidity and mortality. Preventive measures are available, however little is known about the ...

    Mariame Ouedraogo, Jaameeta Kurji, Lakew Abebe, Ronald Labonté in BMC Public Health (2019)

  20. Article

    Open Access

    Association between newborn screening analytes and hypoxic ischemic encephalopathy

    Hypoxic ischemic encephalopathy (HIE) is a major cause of neonatal mortality and morbidity. Our study sought to examine whether patterns of newborn screening analytes differed between infants with and without ...

    Lindsay A. Wilson, Deshayne B. Fell, Steven Hawken, Coralie A. Wong in Scientific Reports (2019)

previous disabled Page of 3